|
| Status |
Public on Aug 16, 2021 |
| Title |
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1 |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34593606 |
| |
| Submission date |
Aug 15, 2021 |
| Last update date |
Nov 15, 2021 |
| Contact name |
Ken Tajima |
| E-mail(s) |
tajiken@juntendo.ac.jp
|
| Phone |
+81-3-5802-1063
|
| Organization name |
Juntendo University
|
| Department |
Department of Respiratory Medicine
|
| Street address |
2-1-1 Hongo
|
| City |
Bunkyo-Ku |
| State/province |
Tokyo |
| ZIP/Postal code |
113-0033 |
| Country |
Japan |
| |
|
| Platforms (2) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL23159 |
[Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay) |
|
| Samples (13)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE181735 |
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1 [array] |
| GSE182153 |
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1 [ATAC-seq] |
|
| Relations |
| BioProject |
PRJNA754799 |
Less...
More...